Literature DB >> 6185482

In vivo quantification of receptor-mediated uptake of asialoglycoproteins by rat liver.

W M Pardridge, A J Van Herle, R T Naruse, G Fierer, A Costin.   

Abstract

The in vivo kinetics of hepatic clearance of 125I-asialo-orosomucoid and 125I-asialofetuin was determined with a portal vein injection technique in barbiturate-anesthetized rats. Nonlinear regression analyses of saturation data gave the following parameters for asialo-orosomucoid, Km = 0.26 +/- 0.06 mg/ml, Vmax = 320 +/- 70 micrograms/min/g, and for asialofetuin, Km = 0.32 +/- 0.07 mg/ml, Vmax = 240 +/- 40 micrograms/min/g. Unlabeled asialofetuin inhibited the clearance of 125I-asialo-orosomucoid with a Ki = 0.25 +/- 0.04 mg/ml. Based on a model assuming that in vivo receptor concentration much greater than receptor KD, then the maximal binding capacity of the external surface of liver cells in vivo for asialo-orosomucoid is 2Km or 520 micrograms/ml or 52 micrograms/g of liver, assuming the liver interstitial space is 0.1 ml/g. Our estimate of in vivo binding capacity approximates in vitro estimates of total hepatic binding capacity, but is 10-fold greater than in vitro estimates of binding capacity on the external surface of liver cells. These results suggest the large majority of asialoglycoprotein receptors are located on the external surface of liver cells. The saturability of 125I-asialo-orosomucoid clearance was also demonstrated with a portal vein double bolus technique, wherein the portal injection of 20-1000 micrograms of unlabeled asialo-orosomucoid was followed 30 s later by the portal injection of tracer. Maximal inhibition of uptake was obtained with a portal vein injection of greater than or equal to 500 micrograms of asialo-orosomucoid. The specific extraction of the 125I-asialo-orosomucoid, which was near zero shortly after a 400-micrograms loading dose, gradually increased toward normal levels with a t1/2 of 21 min. This t1/2 may represent the in vivo rate of receptor recycling, since the gradual increase in unoccupied receptor sites is consistent with the model of receptor binding, internalization, and recycling.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6185482

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

Review 1.  Covalent and noncovalent protein binding of drugs: implications for hepatic clearance, storage, and cell-specific drug delivery.

Authors:  D K Meijer; P van der Sluijs
Journal:  Pharm Res       Date:  1989-02       Impact factor: 4.200

2.  A single-species approach considering additional physiological information for prediction of hepatic clearance of glycoprotein derivate therapeutics.

Authors:  Patrick Poulin
Journal:  Clin Pharmacokinet       Date:  2011-10       Impact factor: 6.447

Review 3.  Receptor-mediated transport of peptide hormones and its importance in the overall hormone disposition in the body.

Authors:  Y Sugiyama; M Hanano
Journal:  Pharm Res       Date:  1989-03       Impact factor: 4.200

4.  Interaction of dietary cholesterol and triglycerides in the regulation of hepatic low density lipoprotein transport in the hamster.

Authors:  D K Spady; J M Dietschy
Journal:  J Clin Invest       Date:  1988-02       Impact factor: 14.808

5.  In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocin-diabetic rats.

Authors:  M Appel; P Potrat; J Feger; C Mas-Chamberlin; G Durand
Journal:  Diabetologia       Date:  1986-06       Impact factor: 10.122

6.  The sites of degradation of rat high-density-lipoprotein apolipoprotein E specifically labelled with O-(4-diazo-3-[125I]iodobenzoyl)sucrose.

Authors:  F M Van't Hooft; A Van Tol
Journal:  Biochem J       Date:  1985-03-15       Impact factor: 3.857

7.  Dietary fish oil stimulates hepatic low density lipoprotein transport in the rat.

Authors:  M A Ventura; L A Woollett; D K Spady
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

8.  Transport of propranolol and lidocaine through the rat blood-brain barrier. Primary role of globulin-bound drug.

Authors:  W M Pardridge; R Sakiyama; G Fierer
Journal:  J Clin Invest       Date:  1983-04       Impact factor: 14.808

9.  In vivo clearance of alpha-1 acid glycoprotein is influenced by the extent of its N-linked glycosylation and by its interaction with the vessel wall.

Authors:  Teresa R McCurdy; Varsha Bhakta; Louise J Eltringham-Smith; Sharon Gataiance; Alison E Fox-Robichaud; William P Sheffield
Journal:  J Biomed Biotechnol       Date:  2012-04-01

10.  Mathematical Models of Blood-Brain Barrier Transport of Monoclonal Antibodies Targeting the Transferrin Receptor and the Insulin Receptor.

Authors:  William M Pardridge; Tom Chou
Journal:  Pharmaceuticals (Basel)       Date:  2021-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.